Publications by authors named "Tim M Reynolds"

Claim this Profile
I
Identification of patients with Fabry disease using routine pathology results: PATHFINDER (eGFR) study.
Tim M Reynolds, Karen L Tylee, Kathryn L Booth, Anthony S Wierzbicki,

Int J Clin Pract· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of patients with Pompé disease using routine pathology results: PATHFINDER (creatine kinase) study.
Tim M Reynolds, Karen Tylee, Kathryn Booth, Anthony S Wierzbicki,

J Clin Pathol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An audit of research productivity in clinical biochemistry revisited.
Tim M Reynolds, Anthony S Wierzbicki

JRSM Open· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demand management of weekend haematology and clinical biochemistry requests.
Tim M Reynolds, Anthony S Wierzbicki

Int J Clin Pract· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sitosterolaemia: a rare cause of accelerated atherosclerosis.
Tim M Reynolds

J Clin Pathol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donald Rumsfeld and point-of-care testing (POCT): the problem of unknown unknowns-venous blood and glucose oxidase-based test strips.
Tim M Reynolds, Tahir S Pillay

J Clin Pathol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are intensive lipid-lowering regimens an optimal economic strategy in patients with ACS? An acute and chronic perspective.
Roberta Ara, Rachid Rafia, Sue E Ward, Anthony S Wierzbicki, Tim M Reynolds

Expert Rev Pharmacoecon Outcomes Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory markers.
Tim M Reynolds

Br J Hosp Med (Lond)· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amylase.
Tim M Reynolds

Br J Hosp Med (Lond)· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological studies are meaningless without proof of long-term data stability.
Tim M Reynolds, Anthony S Wierzbicki, Patrick J Twomey

Am J Med· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new approach to managing prostate cancer is essential.
Tim M Reynolds, Hugh D C Mitchell

Lancet Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized clinical trial comparing 2 support surfaces: results of the Prevention of Pressure Ulcers Study.
Linda J Russell, Tim M Reynolds, Carol Park, Shyam Rithalia, M Gonsalkorale

Adv Skin Wound Care· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemoglobin Wayne in a British family: identification by electrospray ionization/mass spectrometry.
Tim M Reynolds, Tim C Harvey, Brian N Green, Adrian Smith, Andrew J Hartland

Clin Chem· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of nasal bone and detection of trisomy 21.
Tim M Reynolds

Lancet· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis